Literature DB >> 3621622

Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin.

K Miyai, K Ichihara, K Kondo, S Mori.   

Abstract

A total of 10,550 'normal' adults (8450 men and 2100 women) in the general population were screened by a paired assay method for serum PRL and 40 subjects with hyperprolactinaemia (greater than 75 micrograms/l) were detected. Of these, five patients (three men and two women) with pituitary prolactinoma, one man with empty sella syndrome, 10 cases of 'big' prolactinaemia, seven pregnant women and 13 subjects with drug-induced hyperprolactinaemia were found. The patients with prolactinoma had few if any complaints (asymptomatic prolactinoma).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3621622     DOI: 10.1111/j.1365-2265.1986.tb03608.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Prolactinomas and pregnancy.

Authors:  Marcello Delano Bronstein
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

Review 3.  Hyperprolactinaemia.

Authors:  M Hartog; M G Hull
Journal:  BMJ       Date:  1988-09-17

4.  A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.

Authors:  B G Sant' Anna; N R C Musolino; M R Gadelha; C Marques; M Castro; P C L Elias; L Vilar; R Lyra; M R A Martins; A R P Quidute; J Abucham; D Nazato; H M Garmes; M L C Fontana; C L Boguszewski; C B Bueno; M A Czepielewski; E S Portes; V S Nunes-Nogueira; A Ribeiro-Oliveira; R P V Francisco; M D Bronstein; A Glezer
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

Review 5.  Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Authors:  T J Spady; R D McComb; J D Shull
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

6.  Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Authors:  Tracy E Strecker; Thomas J Spady; Beverly S Schaffer; Karen A Gould; Amy E Kaufman; Fangchen Shen; Mac T McLaughlin; Karen L Pennington; Jane L Meza; James D Shull
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

7.  Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats.

Authors:  Terence E Johnson; Mayza Vue; Sharyn Brekhus; Amy Khong; Timothy W C Ho; Ameae M Walker
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

8.  Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.

Authors:  M Guitelman; M E Colombani-Vidal; C C Zylbersztein; L Fiszlejder; M Zeller; O Levalle; H E Scaglia
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

9.  Mass screening for hyperprolactinemia and prolactinoma in men.

Authors:  A Miyake; M Ikegami; C F Chen; N Arita; T Aono; O Tanizawa; T Yoshikawa
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.